scholarly journals Peyronie’s Disease: Management and New Therapeutic Acquisitions

2021 ◽  
Keyword(s):  
Vitamin E ◽  
Disease Management ◽  
Shock Waves ◽  
Erectile Function ◽  
Metabolic Diseases ◽  
Peyronie’S Disease ◽  
Simple Observation ◽  
Long Time ◽  
Peyronie's Disease ◽  
Anti Inflammatory

Peyronie's disease is a condition known for a long time but which has long been stigmatized as a malformation, misunderstood and generating shame and embarrassment on the part of patients. Because of its multifactorial aspect and its association with certain metabolic diseases, the treatment for many years consisted of a simple observation, the prescription of vitamin E or other anti-inflammatory or vasodilator molecules. We present here à new acquisition thanks to the application of linear shock waves, a promising and quite interesting element in the therapeutic arsenal. This technique, especially when coupled with the use of PDE-5 inhibitors and electroporation should make it possible to treat and improve not only punctually the fibrous nodule by improving the elasticity of the tissues concerned, but also of activate the circulation of the cavernous bodies of the penis thus improving erectile function allowing to give hope to many patients who are desperately seeking a solution to their problem.

scholarly journals Peyronie’s Disease: Management and New Therapeutic Acquisitions

2020 ◽  
Vol I (2) ◽  
pp. 25-30
Author(s):  
Alain Bitton
Keyword(s):  
Vitamin E ◽  
Disease Management ◽  
Shock Waves ◽  
Erectile Function ◽  
Metabolic Diseases ◽  
Peyronie’S Disease ◽  
Simple Observation ◽  
Long Time ◽  
Peyronie's Disease ◽  
Anti Inflammatory

Peyronie’s disease is a condition known for a long time but which has long been stigmatized as a malformation, misunderstood and generating shame and embarrassment on the part of patients. Because of its multifactorial aspect and its association with certain metabolic diseases, the treatment for many years consisted of a simple observation, the prescription of vitamin E or other anti-inflammatory or vasodilator molecules. We present here a new acquisition thanks to the application of linear shock waves, a promising and quite interesting element in the therapeutic arsenal. This technique, especially when coupled with the use of PDE-5 inhibitors and electroporation should make it possible to treat and improve not only punctually the fibrous nodule by improving the elasticity of the tissues concerned, but also of activate the circulation of the cavernous bodies of the penis thus improving erectile function allowing to give hope to many patients who are desperately seeking a solution to their problem.

Surgery for disorders of erectile function, ejaculation, and seminal vesicles

2020 ◽  
pp. 631-650
Author(s):  
Suzanne Biers ◽  
Noel Armenakas ◽  
Alastair Lamb ◽  
Stephen Mark ◽  
John Reynard ◽  
...  
Keyword(s):  
Erectile Dysfunction ◽  
Surgical Treatment ◽  
Vascular Surgery ◽  
Erectile Function ◽  
Penile Prosthesis ◽  
Seminal Vesicles ◽  
Peyronie’S Disease ◽  
Surgical Interventions ◽  
Peyronie's Disease

This chapter begins by covering the physiology of erections and ejaculation. It provides ways of evaluating erectile dysfunction and then surgical interventions, including vascular surgery and penile prosthesis. Finally, surgical treatment for Peyronie’s disease is covered.

Erectile Function Profiles in Men With Peyronie’s Disease

2006 ◽  
Vol 175 (5) ◽  
pp. 1807-1811 ◽  
Author(s):  
Serkan Deveci ◽  
Michael Palese ◽  
Marilyn Parker ◽  
Patricia Guhring ◽  
John P. Mulhall
Keyword(s):  
Erectile Function ◽  
Peyronie’S Disease ◽  
Peyronie's Disease

scholarly journals Efficacy of vitamin E in the conservative treatment of Peyronie's disease: legend or reality? A controlled study of 70 cases

Andrology ◽  
2012 ◽  
Vol 1 (1) ◽  
pp. 120-128 ◽  
Author(s):  
G. Paulis ◽  
T. Brancato ◽  
R. D'Ascenzo ◽  
G. De Giorgio ◽  
P. Nupieri ◽  
...  
Keyword(s):  
Vitamin E ◽  
Conservative Treatment ◽  
Peyronie’S Disease ◽  
Controlled Study ◽  
Peyronie's Disease

scholarly journals Smoking, diabetes, blood hypertension: possible etiologic role for Peyronie’s disease? Analysis in 279 patients with a control group in Sicily

2015 ◽  
Vol 87 (1) ◽  
pp. 20 ◽  
Author(s):  
Carlo Pavone ◽  
Francesco D’Amato ◽  
Nino Dispensa ◽  
Federico Torretta ◽  
Carlo Magno
Keyword(s):  
Risk Factors ◽  
Cigarette Smoking ◽  
Outpatient Clinic ◽  
Erectile Function ◽  
Univariate Analysis ◽  
Young Patients ◽  
Significant Risk ◽  
Peyronie’S Disease ◽  
Control Group ◽  
Peyronie's Disease

Objective: To assess the proportion of patients with Peyronie’s Disease (PD) and the possible association with its potential risk factors in the general population of the central and western Sicily in our weekly andrological outpatient clinic. Materials and methods: We recruited a sample of 279 consecutive patients consulting our andrological outpatient clinic. Two arms were created: the first one composed by PD patients (men with symptoms suggestive for PD), the second one composed by patients with other andrological diseases (control arm). For each patient we evaluated the age, cigarette smoking, diabetes, blood hypertension and erectile function. In the PD arm we administered validated questionnaires to determine the erectile function status by the International Index of Erectile Function 5 (IIEF-5) and the pain status during erection by the Visual Analogue Scale (VAS). A univariate analysis was conducted using R software. Results: We enrolled 279 consecutive patients. The number of PD patients was 97 (34,7%). The univariate analysis showed a correlation between PD and cigarette smoking (p = 0.0242), blood hypertension (p < 0.001), erectile dysfunction (p < 0.001). No significant association was observed between diabetes and PD (p = 0.358). The median age of PD arm was 60 years and the median age of the control arm was 63,5 years; therefore the median age of PD arm resulted lower than the median age of the control arm (p = 0,031). Conclusions: Peyronie’s disease is more common than we might think; furthermore it can be diagnosed among young patients. According to our results, cigarette smoking and blood hypertension may be considered statically significant risk factors for developing PD. On the contrary diabetes seems not to be a risk factor for PD. According to our results PD should be sought also in young patients. Further studies are necessary to confirm that removing the indicated risk factors may reduce the incidence of PD.

2013-2014 Updates in Peyronie’s Disease Management

2014 ◽  
Vol 15 (12) ◽  
Author(s):  
Benjamin A. Sherer ◽  
Krishnan Warrior ◽  
Laurence A. Levine
Keyword(s):  
Disease Management ◽  
Peyronie’S Disease ◽  
Peyronie's Disease

scholarly journals Preservation of Cavernosal Erectile Function after Soft Penile Prosthesis Implant in Peyronie's Disease: Long-Term Followup

2008 ◽  
Vol 2008 ◽  
pp. 1-5 ◽  
Author(s):  
Marco Grasso ◽  
Caterina Lania ◽  
Flavio Fortuna ◽  
Salvatore Blanco ◽  
Igor Piacentini
Keyword(s):  
Retrospective Study ◽  
Postoperative Complications ◽  
Sexual Satisfaction ◽  
Erectile Function ◽  
Color Doppler ◽  
Penile Prosthesis ◽  
Peyronie’S Disease ◽  
Penile Shaft ◽  
Peyronie's Disease

The aim of this retrospective study is to evaluate the long-term followup of soft penile SSDA prosthesis, without plaque surgery in the treatment of Peyronie's disease. This study included 12 men with Peyronie's disease who underwent placement of a penile prosthesis. All patients were followed for at least 6 years. Prosthesis straightened the penile shaft in all cases, restoring patient sexual satisfaction. No operative or postoperative complications occurred, and no reoperations were needed. All patients have undergone further examination with basal and dynamic eco color Doppler. The findings are encouraging as the penis preserves the ability to enhance the tumescence and penile girth. We can conclude that SSDA penile prosthesis is safe and effective in Peyronie's disease.

Sign in / Sign up

Export Citation Format

Share Document